Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
17,11 HK$
-0,23%
(-0,040) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
17,32 HK$
High
17,55 HK$
Low
16,88 HK$
Mkt. cap
66,54 млрд
Avg. vol.
3,62 млн
Volume
2,25 млн
Dividend
2,63%
Quarterly dividend
0,11 HK$
Ex-dividend date
2026 ж. 27 шіл.
P/E ratio
11,33
52-wk high
24,84 HK$
52-wk low
14,90 HK$
EPS
1,51 HK$
Shares outstanding
551,94 млн
No. of employees
41 мың
Open
17,32 HK$
High
17,55 HK$
Low
16,88 HK$
Mkt. cap
66,54 млрд
Avg. vol.
3,62 млн
Volume
2,25 млн
Dividend
2,63%
Quarterly dividend
0,11 HK$
Ex-dividend date
2026 ж. 27 шіл.
P/E ratio
11,33
52-wk high
24,84 HK$
52-wk low
14,90 HK$
EPS
1,51 HK$
Shares outstanding
551,94 млн
No. of employees
41 мың
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40,7 мың
Founded1994
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 25 там.
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
10,37 млрд / 10,66 млрд
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
9,88 млрд
12,27 млрд
10,07 млрд
10,37 млрд
Cost of goods sold
5,08 млрд
5,65 млрд
5,07 млрд
5,23 млрд
Cost of revenue
5,08 млрд
5,65 млрд
5,07 млрд
5,23 млрд
Research and development expenses
1,01 млрд
1,28 млрд
896,79 млн
1,19 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 млрд
4,44 млрд
3,27 млрд
3,35 млрд
Operating expense
4,04 млрд
5,92 млрд
4,19 млрд
4,63 млрд
Total operating expenses
9,12 млрд
11,57 млрд
9,26 млрд
9,86 млрд
Operating income
758,38 млн
699,05 млн
813,78 млн
505,27 млн
Other non operating income
-116,85 млн
107,33 млн
2,03 млн
-13,28 млн
EBT including unusual items
1,12 млрд
1,27 млрд
1,36 млрд
1,23 млрд
EBT excluding unusual items
1,49 млрд
1,10 млрд
1,21 млрд
1,07 млрд
Income tax expense
162,98 млн
82,80 млн
277,92 млн
159,73 млн
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 млн
117,57 млн
19,04 млн
74,01 млн
Net income
821,33 млн
847,27 млн
870,83 млн
850,64 млн
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 млрд
732,13 млн
689,67 млн
938,86 млн
Interest expense
-321,25 млн
-291,32 млн
-296,51 млн
-310,88 млн
Net interest expenses
727,28 млн
440,80 млн
393,16 млн
627,98 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 млрд
1,47 млрд
1,59 млрд
1,24 млрд
Gain or loss from assets sale
2,12 млн
-69,35 млн
-
-195,23 м.
AI content may include mistakes. Learn more
Google қолданбалары